Skip to Main Content

Author Details

Ryan D Morin
Simon Fraser University
2005
128
53
PMIDPaper TitleJournal TitlePublished Year
36302166Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.Blood2023
37598282Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.Leukemia2023
37595057Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL.Blood Adv2023
37190862Long non-coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B-cell lymphoma.Br J Haematol2023
37319384Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.J Clin Oncol2023
37084389Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns.Blood2023
36945587Relapse timing is associated with distinct evolutionary dynamics in DLBCL.medRxiv2023
37333387Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL.medRxiv2023
36745874Emerging roles for heterogeneous ribonuclear proteins in normal and malignant B cells.Biochem Cell Biol2023
36701129PeptideRanger: An R Package to Optimize Synthetic Peptide Selection for Mass Spectrometry Applications.J Proteome Res2023
36302254Concerning data inconsistencies in Burkitt lymphoma genome study.Blood2023
34467527Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?Br J Haematol2022
35794478Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.Nature2022
35571031Combinatorial and Machine Learning Approaches for Improved Somatic Variant Calling From Formalin-Fixed Paraffin-Embedded Genome Sequence Data.Front Genet2022
35359007Shared and distinct genetic features in human and canine B-cell lymphomas.Blood Adv2022
36001803Genomic profiling for clinical decision making in lymphoid neoplasms.Blood2022
35963941Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial.Leukemia2022
36351924Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk.Nat Commun2022
36219881Minimal information for reporting a genomics experiment.Blood2022
36253470Author Correction: Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.Nature2022
35039569Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma.Sci Rep2022
32817292Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma.Haematologica2021
33684939Characterization of DLBCL with a PMBL gene expression signature.Blood2021
33904892Treating lymphoma is now a bit EZ-er.Blood Adv2021
33777047Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.Front Immunol2021
34644566Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.Cell Rep2021
34759290Indigenous sex-selective salmon harvesting demonstrates pre-contact marine resource management in Burrard Inlet, British Columbia, Canada.Sci Rep2021
34704593Evolutionary conservation of systemic and reversible amyloid aggregation.J Cell Sci2021
34625792Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.Blood Adv2021
34323958Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.Blood Adv2021
33120427The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.Blood2021
32160292Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.Blood2020
32094924TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.Nat Med2020
33392514PRPS-ST: A protocol-agnostic self-training method for gene expression-based classification of blood cancers.Blood Cancer Discov2020
32636395IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms.Nat Commun2020
32619424TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.Cell2020
32589730Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma.Blood Adv2020
32724107Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR.Sci Rep2020
32151517Integration of Whole-Genome Sequencing With Circulating Tumor DNA Analysis Captures Clonal Evolution and Tumor Heterogeneity in Non-V600 BRAF Mutant Colorectal Cancer.Clin Colorectal Cancer2020
32407529DLBCL subclassification: divide and conquer?Blood2020
32289277A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.Cancer Cell2020
30472330A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens.J Mol Diagn2019
31671154Evaluation of protocols for rRNA depletion-based RNA sequencing of nanogram inputs of mammalian total RNA.PLoS One2019
31527075The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH.Blood2019
31236944Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.J Pathol2019
31510674Collaborative intra-tumor heterogeneity detection.Bioinformatics2019
30779047Ultrasensitive Detection of Circulating Tumor DNA in Lymphoma via Targeted Hybridization Capture and Deep Sequencing of Barcoded Libraries.Methods Mol Biol2019
30744412A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral blood.Biotechniques2019
30705065Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition.Cancer Discov2019
30768166SUBSTRA: Supervised Bayesian Patient Stratification.Bioinformatics2019
  • 1 - 50 of 128

Recommended Authors

Ander Diaz-Navarro
Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo
Career Start Year 2018
Number of shared co-authors 7
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 2
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 10
Francesco Abate
Columbia University
Career Start Year 2012
Number of shared co-authors 5
Jiguang Wang
The Hong Kong University of Science and Technology
Career Start Year 2012
Number of shared co-authors 7
Chris Lawerenz
German Cancer Research Center (DKFZ)
Career Start Year 2011
Number of shared co-authors 7
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 7
Sabah Kadri
Abbvie Inc., Genomics Research Center
Career Start Year 2009
Number of shared co-authors 1
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 21
Hyunchul Jung
Wellcome Sanger Institute
Career Start Year 2009
Number of shared co-authors 2
Ken Chen
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 28
Kilannin Krysiak
Washington University School of Medicine
Career Start Year 2007
Number of shared co-authors 11
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 10
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 17
Jason Walker
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2004
Number of shared co-authors 16
Matthias Schlesner
University of Augsburg
Career Start Year 2004
Number of shared co-authors 13
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 28
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 14
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 18
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 22
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 25
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 16
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 46
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 4
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 33
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 41
Wenming Xiao
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Career Start Year 1997
Number of shared co-authors 6
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 49

Collaborators

Marco A Marra
University of British Columbia
Co-authored papers 66
David W Scott
University of British Columbia
Co-authored papers 38
Steven J M Jones
University of British Columbia
Co-authored papers 30
Andrew J Mungall
Co-authored papers 26
Martin Hirst
University of British Columbia
Co-authored papers 24
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 21
Sohrab P Shah
Memorial Sloan Kettering Cancer Center
Co-authored papers 20
Bruno M Grande
Simon Fraser University
Co-authored papers 19
Richard A Moore
Co-authored papers 15
Robert A Holt
BC Cancer Research Institute
Co-authored papers 10
Malachi Griffith
Washington University
Co-authored papers 9
Lauren C Chong
University of British Columbia
Co-authored papers 9
Ali Bashashati
University of British Columbia
Co-authored papers 8
Samuel Aparicio
University of British Columbia
Co-authored papers 8
Kostiantyn Dreval
Simon Fraser University
Co-authored papers 8
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 7
Tesa M Severson
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers 7
David G Huntsman
University of British Columbia
Co-authored papers 6
Louis M Staudt
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Obi L Griffith
Washington University
Co-authored papers 5
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Ari Melnick
Co-authored papers 5
Prasath Pararajalingam
Simon Fraser University
Co-authored papers 5
Jasleen K Grewal
Monash University
Co-authored papers 4
Yaron S Butterfield
Brain Tumour Foundation of Canada
Co-authored papers 4
Marco A Albuquerque
Ontario Institute for Cancer Research
Co-authored papers 4
Martin Krzywinski
BC Cancer Research Center
Co-authored papers 4
Angela Tam
Co-authored papers 4
Adrian Ally
Co-authored papers 4
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 3
Release 1.2